US Dollar vs Yen

登録してリアルタイムのチャート、分析ツール、価格を入手してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
NLS Pharmaceutics Ltd (NLSP)
NLS Pharmaceutics Ltd (NLSP) ニュース

NLSP

NLS Pharmaceutics (NLSP)

NLS Pharmaceutics Ltd

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:NLSP

1 2 3 4 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/03/12	05 : 01	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:NLSP	NLS Pharmaceutics Ltd
2024/02/24	06 : 00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:NLSP	NLS Pharmaceutics Ltd
2024/01/13	07 : 03	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:NLSP	NLS Pharmaceutics Ltd
2023/12/30	06 : 30	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:NLSP	NLS Pharmaceutics Ltd
2023/12/23	06 : 02	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:NLSP	NLS Pharmaceutics Ltd
2023/12/07	06 : 44	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:NLSP	NLS Pharmaceutics Ltd
2023/12/05	06 : 45	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:NLSP	NLS Pharmaceutics Ltd
2023/12/05	06 : 00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:NLSP	NLS Pharmaceutics Ltd
2023/12/01	21 : 35	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:NLSP	NLS Pharmaceutics Ltd
2023/11/17	06 : 05	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:NLSP	NLS Pharmaceutics Ltd
2023/10/26	05 : 30	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:NLSP	NLS Pharmaceutics Ltd
2023/10/25	22 : 02	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:NLSP	NLS Pharmaceutics Ltd
2023/09/14	05 : 03	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:NLSP	NLS Pharmaceutics Ltd
2023/08/31	06 : 25	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:NLSP	NLS Pharmaceutics Ltd
2023/07/21	05 : 06	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:NLSP	NLS Pharmaceutics Ltd
2023/07/04	02 : 22	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:NLSP	NLS Pharmaceutics Ltd
2023/06/14	21 : 38	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:NLSP	NLS Pharmaceutics Ltd
2023/06/09	21 : 30	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:NLSP	NLS Pharmaceutics Ltd
2023/05/08	21 : 31	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:NLSP	NLS Pharmaceutics Ltd
2023/05/06	05 : 37	Edgar (US Regulatory)	Annual and Transition Report (foreign Private Issuer) (20-f)	NASDAQ:NLSP	NLS Pharmaceutics Ltd
2023/05/02	05 : 31	Edgar (US Regulatory)	Notification That Form 20-f Will Be Submitted Late (nt 20-f)	NASDAQ:NLSP	NLS Pharmaceutics Ltd
2023/02/24	21 : 56	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:NLSP	NLS Pharmaceutics Ltd
2023/02/14	20 : 10	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:NLSP	NLS Pharmaceutics Ltd
2023/02/02	06 : 02	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:NLSP	NLS Pharmaceutics Ltd
2023/01/26	06 : 02	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:NLSP	NLS Pharmaceutics Ltd
2023/01/24	06 : 31	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:NLSP	NLS Pharmaceutics Ltd
2023/01/23	22 : 31	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:NLSP	NLS Pharmaceutics Ltd
2023/01/23	20 : 03	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:NLSP	NLS Pharmaceutics Ltd
2023/01/14	06 : 03	Edgar (US Regulatory)	Securities Registration (foreign Private Issuer) (f-3)	NASDAQ:NLSP	NLS Pharmaceutics Ltd
2023/01/12	22 : 31	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:NLSP	NLS Pharmaceutics Ltd

Showing the most relevant articles for your search:NASDAQ:NLSP

1 2 3 4 次へ >>

Goldman Sachs Bank Usa A...

Morgan Stanley Finance L...

Frankfurt Tec DAX Indica...

Vontobel Financial Produ...

Narragansett Electric (PK)

Hsbc Usa Su Dis

Amundi Index Solutions

Southern California Edis...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約